Department of Chemical Sciences, University of Naples Federico II, Naples 80126, Italy.
Department of Pharmacy, University of Naples Federico II, Naples 80131, Italy.
Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt B):1341-1352. doi: 10.1016/j.bbagen.2017.01.024. Epub 2017 Jan 24.
BACKGROUND: G-quadruplex (G4) structures are key elements in the regulation of cancer cell proliferation and their targeting is deemed to be a promising strategy in anticancer therapy. METHODS: A tandem application of ligand-based virtual screening (VS) calculations together with the experimental G-quadruplex on Oligo Affinity Support (G4-OAS) assay was employed to discover novel G4-targeting compounds. The interaction of the selected compounds with the investigated G4 in solution was analysed through a series of biophysical techniques and their biological activity investigated by immunofluorescence and MTT assays. RESULTS: A focused library of 60 small molecules, designed as putative G4 groove binders, was identified through the VS. The G4-OAS experimental screening led to the selection of 7 ligands effectively interacting with the G4-forming human telomeric DNA. Evaluation of the biological activity of the selected compounds showed that 3 ligands of this sub-library induced a marked telomere-localized DNA damage response in human tumour cells. CONCLUSIONS: The combined application of virtual and experimental screening tools proved to be a successful strategy to identify new bioactive chemotypes able to target the telomeric G4 DNA. These compounds may represent useful leads for the development of more potent and selective G4 ligands. GENERAL SIGNIFICANCE: Expanding the repertoire of the available G4-targeting chemotypes with improved physico-chemical features, in particular aiming at the discovery of novel, selective G4 telomeric ligands, can help in developing effective anti-cancer drugs with fewer side effects. This article is part of a Special Issue entitled "G-quadruplex" Guest Editor: Dr. Concetta Giancola and Dr. Daniela Montesarchio.
背景:G-四链体(G4)结构是调节癌细胞增殖的关键因素,其靶向治疗被认为是一种有前途的抗癌策略。
方法:采用基于配体的虚拟筛选(VS)计算与寡核苷酸亲和支持(G4-OAS)实验相结合的串联应用,以发现新型 G4 靶向化合物。通过一系列生物物理技术分析所选化合物与所研究 G4 在溶液中的相互作用,并通过免疫荧光和 MTT 测定法研究其生物学活性。
结果:通过 VS 鉴定了一个设计为潜在 G4 沟结合物的 60 个小分子的聚焦文库。G4-OAS 实验筛选导致选择了 7 种有效与人类端粒 DNA 形成 G4 的配体。对所选化合物的生物学活性进行评估表明,该亚文库中的 3 种配体在人类肿瘤细胞中诱导了明显的端粒定位 DNA 损伤反应。
结论:虚拟和实验筛选工具的联合应用被证明是识别能够靶向端粒 G4 DNA 的新型生物活性化学型的成功策略。这些化合物可能代表开发更有效和选择性 G4 配体的有用先导物。
一般意义:用改善的物理化学特性扩展可用 G4 靶向化学型的范围,特别是旨在发现新型、选择性的 G4 端粒配体,可以帮助开发副作用更少的有效抗癌药物。本文是题为“G-四链体”的特刊的一部分,客座编辑:Concetta Giancola 博士和 Daniela Montesarchio 博士。
Biochim Biophys Acta Gen Subj. 2017-1-24
Biochim Biophys Acta Gen Subj. 2016-11-9
Biochim Biophys Acta Gen Subj. 2016-11-9
Biochim Biophys Acta Gen Subj. 2016-11-17
Biochim Biophys Acta Gen Subj. 2016-12-23
Biochim Biophys Acta Gen Subj. 2016-12-20
Biochim Biophys Acta Gen Subj. 2016-12-20
Bioinformatics. 2024-6-3
Pharmaceutics. 2023-5-5
Int J Mol Sci. 2022-3-29